中文版 | English

在结果中检索

HFCAS OpenIR

浏览/检索结果: 共3条，第1-3条 帮助

已选(0)清除 条数/页：   排序方式：
Targeting KRAS mutant cancers: from druggable therapy to drug resistance 期刊论文
MOLECULAR CANCER, 2022, 卷号: 21
作者:  Zhu, Chunxiao;  Guan, Xiaoqing;  Zhang, Xinuo;  Luan, Xin;  Song, Zhengbo;  Cheng, Xiangdong;  Zhang, Weidong;  Qin, Jiang-Jiang
收藏  |  浏览/下载：36/0  |  提交时间：2022/12/23
KRAS mutations  Druggable  Resistance  Combination therapy  
CD3D Is an Independent Prognostic Factor and Correlates With Immune Infiltration in Gastric Cancer 期刊论文
FRONTIERS IN ONCOLOGY, 2022, 卷号: 12
作者:  Yuan, Li;  Xu, Jingli;  Shi, Yunfu;  Jin, Zhiyuan;  Bao, Zhehan;  Yu, Pengcheng;  Wang, Yi;  Xia, Yuhang;  Qin, Jiangjiang;  Zhang, Bo;  Yao, Qinghua
收藏  |  浏览/下载：28/0  |  提交时间：2022/12/23
gastric cancer  cd3d  tumor infiltrating lymphocytes (TILs)  prognosis  PD-L1  
Inhibition of STAT3 Signaling Pathway by Terphenyllin Suppresses Growth and Metastasis of Gastric Cancer 期刊论文
FRONTIERS IN PHARMACOLOGY, 2022, 卷号: 13
作者:  Yu, Dehua;  Qi, Simin;  Guan, Xiaoqing;  Yu, Wenkai;  Yu, Xuefei;  Cai, Maohua;  Li, Qinglin;  Wang, Weiyi;  Zhang, Weidong;  Qin, Jiang-Jiang
收藏  |  浏览/下载：33/0  |  提交时间：2022/12/23
STAT3  inhibitor  natural product  gastric cancer  terphenyllin